264 related articles for article (PubMed ID: 17449028)
21. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
[TBL] [Abstract][Full Text] [Related]
22. V1a vasopressin receptor expression is modulated during myogenic differentiation.
Alvisi M; De Arcangelis V; Ciccone L; Palombi V; Alessandrini M; Nemoz G; Molinaro M; Adamo S; Naro F
Differentiation; 2008 Apr; 76(4):371-80. PubMed ID: 18021262
[TBL] [Abstract][Full Text] [Related]
23. Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Vascul Pharmacol; 2007 Jun; 46(6):463-9. PubMed ID: 17395547
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
[TBL] [Abstract][Full Text] [Related]
25. [Vasopressin receptor knockout mice as an animal model of psychiatric disorders].
Egashira N; Tanoue A; Tsujimoto G; Mishima K; Takano Y; Iwasaki K; Fujiwara M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Apr; 26(2):101-5. PubMed ID: 16722468
[TBL] [Abstract][Full Text] [Related]
26. Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice.
Egashira N; Tanoue A; Matsuda T; Koushi E; Harada S; Takano Y; Tsujimoto G; Mishima K; Iwasaki K; Fujiwara M
Behav Brain Res; 2007 Mar; 178(1):123-7. PubMed ID: 17227684
[TBL] [Abstract][Full Text] [Related]
27. Vasopressin V1A receptor enhances baroreflex via the central component of the reflex arc.
Oikawa R; Nasa Y; Ishii R; Kuwaki T; Tanoue A; Tsujimoto G; Takeo S
Eur J Pharmacol; 2007 Mar; 558(1-3):144-50. PubMed ID: 17224142
[TBL] [Abstract][Full Text] [Related]
28. Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus.
Nishikawa T; Omura M; Iizuka T; Saito I; Yoshida S
Arzneimittelforschung; 1996 Sep; 46(9):875-8. PubMed ID: 8876935
[TBL] [Abstract][Full Text] [Related]
29. Effects of vasopressin V1b receptor deficiency on adrenocorticotropin release from anterior pituitary cells in response to oxytocin stimulation.
Nakamura K; Fujiwara Y; Mizutani R; Sanbe A; Miyauchi N; Hiroyama M; Yamauchi J; Yamashita T; Nakamura S; Mori T; Tsujimoto G; Tanoue A
Endocrinology; 2008 Oct; 149(10):4883-91. PubMed ID: 18583426
[TBL] [Abstract][Full Text] [Related]
30. Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene.
Watters JJ; Swank MW; Wilkinson CW; Dorsa DM
Peptides; 1996; 17(1):67-73. PubMed ID: 8822512
[TBL] [Abstract][Full Text] [Related]
31. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
32. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.
Koshimizu TA; Nasa Y; Tanoue A; Oikawa R; Kawahara Y; Kiyono Y; Adachi T; Tanaka T; Kuwaki T; Mori T; Takeo S; Okamura H; Tsujimoto G
Proc Natl Acad Sci U S A; 2006 May; 103(20):7807-12. PubMed ID: 16682631
[TBL] [Abstract][Full Text] [Related]
33. Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V
Taveau C; Chollet C; Bichet DG; Velho G; Guillon G; Corbani M; Roussel R; Bankir L; Melander O; Bouby N
Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E127-E135. PubMed ID: 27998960
[TBL] [Abstract][Full Text] [Related]
34. The stimuli-specific role of vasopressin in the hypothalamus-pituitary-adrenal axis response to stress.
Zelena D; Domokos A; Jain SK; Jankord R; Filaretova L
J Endocrinol; 2009 Aug; 202(2):263-78. PubMed ID: 19460853
[TBL] [Abstract][Full Text] [Related]
35. Expression of arginine vasopressin and vasopressin V1a receptor mRNA in diabetic (db/db) mice.
Morita M; Kita Y; Morikawa N; Iwami M; Notsu Y
Exp Clin Endocrinol Diabetes; 2001; 109(5):261-6. PubMed ID: 11507649
[TBL] [Abstract][Full Text] [Related]
36. Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.
Serradeil-Le Gal C; Bourrié B; Raufaste D; Carayon P; Garcia C; Maffrand JP; Le Fur G; Casellas P
Biochem Pharmacol; 1994 Feb; 47(4):633-41. PubMed ID: 8129742
[TBL] [Abstract][Full Text] [Related]
37. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
Reymond-Marron I; Tribollet E; Raggenbass M
Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.
Barbeis C; Balestre MN; Jard S; Tribollet E; Arsenijevic Y; Dreifuss JJ; Bankowski K; Manning M; Chan WY; Schlosser SS
Neuroendocrinology; 1995 Aug; 62(2):135-46. PubMed ID: 8584113
[TBL] [Abstract][Full Text] [Related]
39. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
[TBL] [Abstract][Full Text] [Related]
40. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
